Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant RT +/- Hormone Therapy in High Risk Prostate Cancer
NCT00023829Phase 3Completed
- Sponsor
- NRG Oncology
- Start
- Aug 2001
- Primary completion
- Jun 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of flutamide, bicalutamide in prostate cancer (PCa), sponsored by NRG Oncology. Started Aug 2001; status: completed.
02
Drugs
flutamidebicalutamide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00023829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00023829.